Companies
Senco Gold targets 20–25% revenue growth in FY27 but cautions PAT margins will normalise to 4–4.5%
Senco Gold's top executive signals a return to normal profit margins. FY26's high earnings were an exception. The company aims for 4-4.5% profit margins going forward. Demand saw a dip but is expected to recover. Senco Gold plans to open more stores and boost diamond jewellery sales. Inventory is largely protected against price swings.
Tata Steel CEO TV Narendran cautiously optimistic; sees strong Q1 ahead as steel prices rise across India, UK, & Europe
Tata Steel CEO TV Narendran flags multi-point cost pressure from the West Asia crisis but says the company has so far recovered most input cost increases from the market. Narendran eyes a stronger Q1 FY27 with better prices in India, the UK, and the Netherlands. India's volume growth and UK policy support are key drivers.
Medanta expects Noida hospital to turn cash positive within months as expansion drive accelerates
Medanta's new Noida hospital is projected to become cash positive within three to four months, with its startup losses being the primary reason for a recent margin dip. Established facilities are performing strongly, and the company plans significant brownfield bed expansion alongside new greenfield projects, aiming for a consolidated EBITDA margin of 24-26%.
Gold import duty hike triggers buying rush and volume concerns, says Senco Gold MD
India's gold jewellery market is adjusting to a new reality. An import duty hike is causing consumers to rush purchases. Industry experts predict a drop in sales volumes. Consumers are expected to opt for lighter, lower-value jewellery. This shift could also benefit retailers through higher margins on lower karatage items. Old gold exchanges are likely to increase.
Canara Bank sees NIM floor at 2.5%, confident of absorbing ECL hit without fresh equity
Canara Bank anticipates a strong FY27. Margins are stable, and asset quality remains robust. The bank can manage upcoming provisioning needs without raising fresh capital. Deposit growth is expected to continue at a healthy pace. Operating profits are projected to grow substantially. Return on assets will be maintained above 1 percent.
SBI posts record ₹80,000 crore profit; chairman says NIM has bottomed out, eyes 13–15% loan growth in FY27
State Bank of India achieved a record profit exceeding ₹80,000 crore. Despite investor concerns over net interest income and margin, Chairman CS Setty assured that the worst is over, with Net Interest Margins expected to stabilize around 3%. The bank also reported strong deposit growth and anticipates robust loan expansion across all segments, while closely monitoring global risks.
BULL'S EYE
6 smart moves to take control of your debt before it controls you
6 money myths that are stopping you from building wealth
Income Tax Department busts fake tax deduction racket
Sovereign Gold Bond 2017-18 Series I final redemption announced
Prices of LPG cylinder in Delhi, Mumbai, Kolkata
HDFC Mutual Fund "Tap2Invest" on WhatsApp
Should you opt for the old tax regime, or the new tax regime ?
Money deadlines in March 2025
Top 5 ELSS funds with up to 23% returns in 3 years
Market Movers
Markets Videos
Kiran Mazumdar-Shaw names niece Claire as successor, targets semaglutide push from FY28; debt cut to $1.1 billion
Biocon's Executive Chairperson, Kiran Mazumdar-Shaw, outlined a five-year leadership transition with her niece, Claire Mazumdar, as successor. The company anticipates a strong FY27 launch calendar, particularly in the second half, with a focus on its "diabesity franchise." Significant debt reduction has been achieved, with further operational cash flow prioritized for additional deleveraging.
Muthoot Microfin grew 13% when the industry shrank 20%; CEO explains what's next
Muthoot Microfin defied industry decline, growing assets by over 13%. The company improved its loan repayment rates and reduced bad loans. New individual loan products are performing exceptionally well. Sadaf Sayeed, CEO of Muthoot Microfin anticipates further margin expansion and improved profitability in the coming years, signaling a strong recovery.
Marico CEO Saugata Gupta confident of double-digit revenue growth, eyes Rs 15,000 crore target by FY27
Marico's MD Saugata Gupta is confident of hitting Rs 15,000 crore revenue by FY27, driven by Parachute's resilience despite price hikes and easing input costs. Value-added hair oils and foods are also boosting diversification. The company prioritizes premium offerings for Saffola, aiming for profitable growth while monitoring potential El Nino impacts.
Capri Global Capital targets ₹55,000 crore AUM by FY28; gold loans and co-lending drive profitability: Rajesh Sharma
Capri Global Capital is targeting ₹55,000 crore in assets under management by FY28. The non-banking financial company is focusing on growth through gold loans and co-lending arrangements. This strategy aims to boost fee income while maintaining profitability. The company plans significant expansion in its gold loan branch network over the next three years.
Bandhan Bank targets 15% credit growth and ROA of 1.5% in FY27 as asset quality improves
Bandhan Bank is showing signs of recovery, with its Managing Director and CEO highlighting a repaired balance sheet and cautious optimism for the future. The bank has seen NIMs stabilize due to lower funding costs and reduced slippages, while asset quality has significantly improved, leading to a downward trend in credit costs.
Maruti targets 10% growth in FY27 but margin pressure lingers, says RC Bhargava
Maruti Suzuki anticipates a strong 10% volume growth in FY27, supported by new production lines. The company's outlook is bolstered by healthy demand, especially from rural markets. Margin recovery will be a gradual process, with Maruti carefully managing input cost increases. Exports are expected to remain stable. The company is well-positioned for the upcoming fiscal year.
Sun Pharma-Organon deal: How a $12-billion merger will reshape India's pharma landscape
Sun Pharma is set to nearly double its revenue to $12 billion with the acquisition of Organon, creating a global pharmaceutical giant. The deal leverages Organon's strengths in women's health, biosimilars, and established brands, aiming for significant growth despite geopolitical concerns. Integration plans and manageable debt are key to the strategic move.
IDFC First Bank deposit growth returning to 20%, credit costs falling, no West Asia impact yet: V Vaidyanathan
IDFC First Bank's CEO V Vaidyanathan stated that the deliberate slowdown in deposit growth during Q4 was temporary and already reversing, with April data showing strong momentum. He expressed confidence in achieving 20% annual deposit growth in FY27, alongside lower credit costs and controlled operating expenses, indicating a robust financial outlook.
Tata Capital targets 23–25% loan growth through FY28, bets on GenAI and falling credit costs to boost returns
Tata Capital anticipates strong performance in FY27, driven by growth, improved margins, and operating efficiency. The company has seen a consistent decline in credit costs, a trend expected to continue due to a disciplined risk culture and the adoption of AI. Loan book growth is projected to be robust, with a focus on housing finance and retail products.
SBI Life delivers on guidance, targets double-digit protection share in medium term
SBI Life Insurance achieved its financial targets for FY26. The company is now prioritizing its protection business and agency channel. It aims to reduce reliance on ULIP products for better margins. SBI Life is investing in agent training with AI tools. The company is prepared for regulatory changes. Its strategy focuses on disciplined execution and future growth.
